1998
DOI: 10.2337/diacare.21.5.777
|View full text |Cite
|
Sign up to set email alerts
|

Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995

Abstract: Few diabetic Medicare beneficiaries in Washington, Alaska, and Idaho had claims for reimbursement for therapeutic footwear in 1995. The low utilization of the footwear benefit may represent an important opportunity to improve care for Medicare beneficiaries with diabetes. Further work should be done to characterize the use of the benefit in other regions and to assess whether the low level of usage reflects underutilization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 2 publications
(3 reference statements)
0
18
0
Order By: Relevance
“…Other reports suggest a poor referral pattern for therapeutic shoes as well. In a study by Sugarman et al (11) only 2.9% of subjects with diabetes that met the criteria for “high risk” received therapeutic footwear. Although the high rate of amputation may be due to our study patients' inherent risk for foot complications, it is possible that poorly utilized prevention services played a role.…”
Section: Discussionmentioning
confidence: 99%
“…Other reports suggest a poor referral pattern for therapeutic shoes as well. In a study by Sugarman et al (11) only 2.9% of subjects with diabetes that met the criteria for “high risk” received therapeutic footwear. Although the high rate of amputation may be due to our study patients' inherent risk for foot complications, it is possible that poorly utilized prevention services played a role.…”
Section: Discussionmentioning
confidence: 99%
“…28 We also conducted a sensitivity analysis that excluded patients who had codes indicating a lower extremity joint replacement in 2003.…”
Section: Methodsmentioning
confidence: 99%
“…However, most patients do not receive the type of clinical evaluation and standard prevention therapies that are recommended by the American Diabetes Association, the International Working Group on the Diabetic Foot, and the American College of Foot and Ankle Surgeons [15,16]. For instance, Sugarman et al [17] indicated that less than 3% of eligible diabetic patients receive therapeutic shoe and insoles in the United States.…”
Section: Failure Of Standard Prevention Therapiesmentioning
confidence: 97%